A Comparative Study of Continuous Electrocardiographic Monitoring with Holter Monitoring to Detect Paroxysmal AF in Acute Ischemic Stroke.
Keywords:
Continuous Electrocardiographic Monitoring (CEM), Holter monitoring, Atrial fibrillation (AF), Acute ischemic strokeAbstract
Background: Paroxysmal atrial fibrillation (AF) is an important cause of acute ischemic stroke. Although Holter monitoring is the standard diagnostic modality, its use is limited by device availability and short monitoring duration. Continuous electrocardiographic monitoring (CEM), widely implemented in stroke units, may provide a practical alternative in general hospital settings. Methods: This prospective cohort study with historical controls included patients aged >65 years with acute ischemic stroke admitted to the Stroke Unit of Nakhon Pathom Hospital from January 2019 to December 2024. AF detection rates between CEM and Holter monitoring were compared. All patients were followed continuously for AF occurrence and thromboembolic event for 1 year after the index stroke. Results: AF detection rates did not differ significantly between CEM and Holter monitoring. Factors associated with Higher AF detection included cardioembolism (OR 20.69; 95% CI 2.65–161.74; p = 0.006) and CHA₂DS₂-VASc score >5 (OR 5.72; 95% CI 0.82–39.81; p = 0.045). The cost per AF detected was substantially lower with CEM (2,067.7 THB) compared with Holter monitoring (32,800 THB). One-year follow-up identified 1 new AF case, 4 recurrent strokes, and 9 deaths. Conclusion: CEM Provided AF detection performance comparable to Holter monitoring while demonstrating superior markedly greater cost-effectiveness, particularly among high-risk groups such as patient with cardioembolism/ESUS or elevated CHA₂DS₂-VASc scores. These findings support CEM as a practical and efficient approach for AF surveillance in routine stroke unit careReferences
Johnson W, Onuma O, Owolabi M, Sachdev S. Stroke: a global response is needed. Bull World Health Organ. 2016;94(9):634-A. doi: 10.2471/BLT.16.181636.
Khoo CW, Lip GY. Clinical outcomes of acute stroke patients with atrial fibrillation. Expert Rev Cardiovasc Ther. 2009;7(4):371-4. doi: 10.1586/erc.09.11.
Kamel H, Healey JS. Cardioembolic Stroke. Circ Res. 2017;120(3):514-26. doi: 10.1161/CIRCRESAHA.116. 308407.
Kamel H, Okin PM, Elkind MS, Iadecola C. Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model. Stroke. 2016;47(3):895-900. doi: 10.1161/STROKEAHA.115.012004.
Sanders GD, Lowenstern A, Borre E, Chatterjee R, Goode A, Sharan L, et al. Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Oct. Report No.: AHRQ 18-EHC018-EFReport No.: PCORI® 2018-SR-04.
Patel J, Bhaskar SMM. Diagnosis and Management of Atrial Fibrillation in Acute Ischemic Stroke in the Setting of Reperfusion Therapy: Insights and Strategies for Optimized Care. J Cardiovasc Dev Dis. 2023;10(11):458. doi: 10.3390/jcdd10110458.
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364-e467. doi: 10.1161/STR.0000000000000375.
Lotufo PA. Stroke prevention within primary care: management of atrial fibrillation using oral anticoagulation. Sao Paulo Med J. 2018;136(4):273-5. doi: 10.1590/1516-3180.2018.1364110718
Sandra SG, María MF, de la Hera Galarza JM, Sergio CP. Atrial Fibrillation in Cryptogenic Stroke: New Tools Needed for Diagnosis?.Rev Esp Cardiol. 2014;67(2):665-76. Doi: 110.1016/j.rec.2013.10.004.
Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology. 2013;80(17):1546-50. doi: 10.1212/WNL.0b013e31828f1828.
Toyoda K, Kusano K, Iguchi Y, Ikeda T, Morishima I, Tomita H, et al. Global Results of Implantable Loop Recorder for Detection of Atrial Fibrillation After Stroke: Reveal LINQ Registry. J Am Heart Assoc. 2024;13(21):e035956. doi: 10.1161/JAHA.124.035956.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41. doi: 10.1161/01.str.24.1.35.
Saver JL. CLINICAL PRACTICE. Cryptogenic Stroke. N Engl J Med. 2016;374(21):2065-74. doi: 10.1056/NEJMcp1503946.
Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467-77. doi: 10.1056/NEJMoa1311376.
Zhang C, Kasner SE. Paroxysmal Atrial Fibrillation in Cryptogenic Stroke: an Overlooked Explanation? Curr Atheroscler Rep. 2015;17(12):66. doi: 10.1007/s11883-015-0547-0.
Gannon KP. Cryptogenic Stroke & Embolic Stroke of Undetermined Score. What do we know and where do we go from here?. Practical neurology.2019;July-Aug:92-4.
Perera KS, Vanassche T, Bosch J, Giruparajah M, Swaminathan B, Mattina KR, et al. ESUS Global Registry Investigators. Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry. Int J Stroke. 2016;11(5):526-33. doi: 10.1177/1747493016641967.
Diener HC, Endres M. Vergangenheit und Zukunft des ESUS-Konzepts [Past and future of the ESUS concept]. Nervenarzt. 2020;91(6):511-7. Doi: /10.1007/s00115-020-00893-1
Suwanwela NC. Stroke epidemiology in Thailand. J Stroke. 2014;16(1):1-7. doi: 10.5853/jos.2014.16.1.1.
Huang WY, Lee M, Sung SF, Tang SC, Chang KH, Huang YS, et al. Atrial fibrillation trial to evaluate real-world procedures for their utility in helping to lower stroke events: A randomized clinical trial. Int J Stroke. 2021;16(3):300-10. doi: 10.1177/1747493020938297.
Sutamnartpong P, Dharmasaroja PA, Ratanakorn D, Arunakul I. Atrial fibrillation and paroxysmal atrial fibrillation detection in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(5):1138-41. doi: 10.1016/j.jstrokecerebrovasdis.2013.09.032.
Ngamtrairai P. Detection of Atrial Fibrillation by Holter Monitoring in Elderly Patients with Ischemic Stroke. J Thai stroke Soc. 2021;20(1):5-14.
Choi HY, Seo JH, Yang JH, Kim YD, Jung YH, Cho HJ, et al. Beneficial effects of stroke-unit care in stroke patients with atrial fibrillation. Yonsei Med J. 2013;54(2):301-5. doi: 10.3349/ymj.2013.54.2.301.
Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012;43(10):2689-94. doi: 10.1161/STROKEAHA.112.654954.
Suissa L, Lachaud S, Mahagne MH. Continuous ECG monitoring for tracking down atrial fibrillation after stroke: Holter or automated analysis strategy? Eur Neurol. 2014;72(1-2):7-12. doi: 10.1159/000358053
Suissa L, Lachaud S, Mahagne MH. Optimal timing and duration of continuous electrocardiographic monitoring for detecting atrial fibrillation in stroke patients. J Stroke Cerebrovasc Dis. 2013;22(7):991-5. doi: 10.1016/j.jstrokecerebrovasdis.2012.01.015.
Lazzaro MA, Krishnan K, Prabhakaran S. Detection of atrial fibrillation with concurrent holter monitoring and continuous cardiac telemetry following ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis. 2012;21(2):89-93. doi: 10.1016/j.jstrokecerebrovasdis.2010.05.006.
Gumbinger C, Krumsdorf U, Veltkamp R, Hacke W, Ringleb P. Continuous monitoring versus HOLTER ECG for detection of atrial fibrillation in patients with stroke. Eur J Neurol. 2012;19(2):253-7. doi: 10.1111/j.1468-1331.2011.03519.x.
Tsunetoshi C, Tsunetoshi K, Komori O, Higashino Y, Isozaki M, Arai Y, et al. Factors affecting reasonable duration of continuous electrocardiographic monitoring to detect atrial fibrillation in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2023;32(8):107173. doi: 10.1016/j.jstrokecerebrovasdis.2023.107173.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Journal of Thai Stroke Society

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ข้อความภายในบทความที่ตีพิมพ์ในวารสารสมาคมโรคหลอดเลือดสมองไทยเล่มนี้ ตลอดจนความรับผิดชอบด้านเนื้อหาและการตรวจร่างบทความเป็นของผู้นิพนธ์ ไม่เกี่ยวข้องกับกองบรรณาธิการแต่อย่างใด การนำเนื้อหา ข้อความหรือข้อคิดเห็นของบทความไปเผยแพร่ ต้องได้รับอนุญาตจากกองบรรณาธิการอย่างเป็นลายลักษณ์อักษร ผลงานที่ได้รับการตีพิมพ์ในวารสารเล่มนี้ถือเป็นลิขสิทธิ์ของวารสาร

